Objective: To evaluate early-pregnancy changes in lipid profile in recurrent preeclampsia. Methods: In this retrospective observational study, blood samples were obtained from 41 normotensive women with a history of early-onset preeclampsia preconceptionally and at 12 and 16 weeks in the next pregnancy. We assessed triglycerides (TGs), total cholesterol (TC), and high- and low-density lipoprotein cholesterol (HDL-C and LDL-C, respectively). We analyzed differences in longitudinal patterns between normal and recurrent preeclamptic next pregnancy using mixed-design repeated measurements analysis of covariance (ANCOVA). Results: Eleven (28%) women developed recurrent preeclampsia. Eighteen (45%) women had a normal pregnancy. In normal pregnancy, LDL-C declines transiently in the first trimester (P < .01). In women who develop recurrent preeclampsia later on this decline was absent. Moreover, from 12 weeks onward the elevating levels of HDL-C stagnates in women who subsequently develop recurrent preeclampsia (P = .02). Conclusion: These observations point to an abnormal early adaptation of lipid metabolism to pregnancy preceding clinical manifestation of preeclampsia.
DarmadyJMPostleAD. Lipid metabolism in pregnancy. Br J Obstet Gynaecol. 1982;89(3):211–215.
2.
FahraeusLLarsson-CohnUWallentinL. Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol. 1985;66(4):468–472.
3.
ButteNF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(5 suppl):1256S–1261S.
4.
BakerAMKleinRLMossKLHaeriSBoggessK. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol. 2009;201(3):293 e1–4.
5.
ClausenTDjurovicSHenriksenT. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG. 2001;108(10):1081–1087.
6.
EnquobahrieDAWilliamsMAButlerCLFrederickIOMillerRSLuthyDA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens. 2004;17(7):574–581.
7.
HubelCAMcLaughlinMKEvansRWHauthBASimsCJRobertsJM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 1996;174(3):975–982.
8.
OguraKMiyatakeTFukuiONakamuraTKamedaTYoshinoG. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb. 2002;9(1):42–47.
9.
SattarNBendomirABerryCShepherdJGreerIAPackardCJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89(3):403–408.
10.
ZiaeiSBonabKMKazemnejadA. Serum lipid levels at 28-32 weeks gestation and hypertensive disorders. Hypertens Pregnancy. 2006;25(1):3–10.
JauniauxEJurkovicDCampbellSHustinJ. Doppler ultrasonographic features of the developing placental circulation: Correlation with anatomic findings. Am J Obstet Gynecol. 1992;166(2):585–587.
13.
RobertsJMHubelCA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(suppl A):S32–S37.
14.
HuppertzBFrankHGKingdomJCReisterFKaufmannP. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol. 1998;110(5):495–508.
15.
HuppertzBKingdomJC. Apoptosis in the trophoblast–role of apoptosis in placental morphogenesis. J Soc Gynecol Investig. 2004;11(6):353–362.
16.
MayhewTM. A stereological perspective on placental morphology in normal and complicated pregnancies. J Anat. 2009;215(1):77–90.
17.
FormigliLPapucciLTaniA. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 2000;182(1):41–49.
18.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.
19.
SibaiBM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5 pt 1):981–991.
20.
The Netherlands Perinatal Registry. NPR-foundation. http://www.perinatreg.nl/. Accessed April, 2009.
21.
FriedewaldWTLevyRIFredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
22.
LongfordN. Single imputation and related methods. In: FienbergSvan der LindenW eds. Missing Data and Small-Area Estimation. London: Springer; 2005:37–58.
23.
AtkinsonG. Analysis of repeated measurements in physical therapy research: multiple comparisons amongst level means and multi-factorial designs. Phys Therapy Sport. 2002;3:191–203.
24.
LoftusGMassonM. Using confidence intervals in within-subject designs. Psychonomic Bull Rev. 1994;1:476–490.
25.
Di CianniGMiccoliRVolpeLLencioniCDel PratoS. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 2003;19(4):259–270.
26.
InnesKEByersTE. Preeclampsia and breast cancer risk. Epidemiology. 1999;10(6):722–732.
27.
ZeislerHJirecekSHohlagschwandtnerMKnoflerMTempferCLivingstonJC. Concentrations of estrogens in patients with preeclampsia. Wien Klin Wochenschr. 2002;114(12):458–461.
28.
SepSJSmitsLJPrinsMHSpaandermanMEPeetersLL. Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy. Reprod Sci. 2009;16(1):80–87.
29.
Ware-JaureguiSSanchezSEZhangCLaraburreGKingIBWilliamsMA. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet. 1999;67(3):147–155.
30.
WilliamsMAWoelkGBKingIBJenkinsLMahomedK. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens. 2003;16(8):665–672.
31.
NorataGDCatapanoAL. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag. 2005;1(2):119–129.
